# Evaluation of the Clinical Outcome of Cyclosporine Short Infusion Versus Continuous Infusion Post Allogenic Stem Cell Transplantation

> **NCT04575779** · — · COMPLETED · sponsor: **Shaymaa Mohammed El-Awady** · enrollment: 31 (actual)

## Conditions studied

- Allogenic Bone Marrow Transplantation

## Interventions

- **DRUG:** Cyclosporin with a daily dose of 3 mg/kg/day intravenously over 2 h (short infusion) every 12 h

## Key facts

- **NCT ID:** NCT04575779
- **Lead sponsor:** Shaymaa Mohammed El-Awady
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-10
- **Primary completion:** 2021-04-04
- **Final completion:** 2022-05-30
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2023-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04575779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04575779, "Evaluation of the Clinical Outcome of Cyclosporine Short Infusion Versus Continuous Infusion Post Allogenic Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04575779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*